204 related articles for article (PubMed ID: 25956175)
1. A multicopper oxidase contributes to the copper tolerance of Brucella melitensis 16M.
Wu T; Wang S; Wang Z; Peng X; Lu Y; Wu Q
FEMS Microbiol Lett; 2015 Jun; 362(12):fnv078. PubMed ID: 25956175
[TBL] [Abstract][Full Text] [Related]
2. The effects of RegM on stress responses in Brucella melitensis.
Dong H; Liu W; Peng X; Wu Q
Curr Microbiol; 2015 May; 70(5):730-4. PubMed ID: 25648428
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of defined Brucella melitensis wboA mutants.
Nikolich MP; Warren RL; Lindler LE; Izadjoo MJ; Hoover DL
Vaccine; 2010 Oct; 28 Suppl 5():F12-6. PubMed ID: 20362622
[TBL] [Abstract][Full Text] [Related]
4. TceSR two-component regulatory system of Brucella melitensis 16M is involved in invasion, intracellular survival and regulated cytotoxicity for macrophages.
Li Z; Fu Q; Wang Z; Li T; Zhang H; Guo F; Wang Y; Zhang J; Chen C
Lett Appl Microbiol; 2015 Jun; 60(6):565-71. PubMed ID: 25721466
[TBL] [Abstract][Full Text] [Related]
5. Brucella melitensis 16M: characterisation of the galE gene and mouse immunisation studies with a galE deficient mutant.
Petrovska L; Hewinson RG; Dougan G; Maskell DJ; Woodward MJ
Vet Microbiol; 1999 Feb; 65(1):21-36. PubMed ID: 10068125
[TBL] [Abstract][Full Text] [Related]
6. The putative penicillin-binding proteins 1 and 2 are important for viability, growth and cell morphology of Brucella melitensis.
Bandara AB; Schurig GG; Sriranganathan N; Prasad R; Boyle SM
Vet Microbiol; 2009 Feb; 133(4):387-93. PubMed ID: 18809265
[TBL] [Abstract][Full Text] [Related]
7. Molecular screening for rifampicin and fluoroquinolone resistance in a clinical population of Brucella melitensis.
Valdezate S; Navarro A; Medina-Pascual MJ; Carrasco G; Saéz-Nieto JA
J Antimicrob Chemother; 2010 Jan; 65(1):51-3. PubMed ID: 19861338
[TBL] [Abstract][Full Text] [Related]
8. Intracellular rescuing of a B. melitensis 16M virB mutant by co-infection with a wild type strain.
Nijskens C; Copin R; De Bolle X; Letesson JJ
Microb Pathog; 2008 Aug; 45(2):134-41. PubMed ID: 18547782
[TBL] [Abstract][Full Text] [Related]
9. Survival of a bacterioferritin deletion mutant of Brucella melitensis 16M in human monocyte-derived macrophages.
Denoel PA; Crawford RM; Zygmunt MS; Tibor A; Weynants VE; Godfroid F; Hoover DL; Letesson JJ
Infect Immun; 1997 Oct; 65(10):4337-40. PubMed ID: 9317046
[TBL] [Abstract][Full Text] [Related]
10. Autophagy favors Brucella melitensis survival in infected macrophages.
Guo F; Zhang H; Chen C; Hu S; Wang Y; Qiao J; Ren Y; Zhang K; Wang Y; Du G
Cell Mol Biol Lett; 2012 Jun; 17(2):249-57. PubMed ID: 22367856
[TBL] [Abstract][Full Text] [Related]
11. The Ton system, an ABC transporter, and a universally conserved GTPase are involved in iron utilization by Brucella melitensis 16M.
Danese I; Haine V; Delrue RM; Tibor A; Lestrate P; Stevaux O; Mertens P; Paquet JY; Godfroid J; De Bolle X; Letesson JJ
Infect Immun; 2004 Oct; 72(10):5783-90. PubMed ID: 15385478
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the virulence of a Brucella melitensis hemagglutinin gene in the caprine model.
Perry QL; Hagius SD; Walker JV; Elzer PH
Vaccine; 2010 Oct; 28 Suppl 5():F6-11. PubMed ID: 20362205
[TBL] [Abstract][Full Text] [Related]
13. A Multicopper oxidase (Cj1516) and a CopA homologue (Cj1161) are major components of the copper homeostasis system of Campylobacter jejuni.
Hall SJ; Hitchcock A; Butler CS; Kelly DJ
J Bacteriol; 2008 Dec; 190(24):8075-85. PubMed ID: 18931123
[TBL] [Abstract][Full Text] [Related]
14. Complete genome-wide screening and subtractive genomic approach revealed new virulence factors, potential drug targets against bio-war pathogen Brucella melitensis 16M.
Pradeepkiran JA; Sainath SB; Kumar KK; Bhaskar M
Drug Des Devel Ther; 2015; 9():1691-706. PubMed ID: 25834405
[TBL] [Abstract][Full Text] [Related]
15. Identification of the perosamine synthetase gene of Brucella melitensis 16M and involvement of lipopolysaccharide O side chain in Brucella survival in mice and in macrophages.
Godfroid F; Taminiau B; Danese I; Denoel P; Tibor A; Weynants V; Cloeckaert A; Godfroid J; Letesson JJ
Infect Immun; 1998 Nov; 66(11):5485-93. PubMed ID: 9784561
[TBL] [Abstract][Full Text] [Related]
16. Rifampicin resistance phenotyping of Brucella melitensis by rpoB gene analysis in clinical isolates.
Sayan M; Yumuk Z; Dündar D; Bilenoglu O; Erdenlig S; Yaşar E; Willke A
J Chemother; 2008 Aug; 20(4):431-5. PubMed ID: 18676221
[TBL] [Abstract][Full Text] [Related]
17. A Brucella melitensis high temperature requirement A (htrA) deletion mutant demonstrates a stress response defective phenotype in vitro and transient attenuation in the BALB/c mouse model.
Phillips RW; Elzer PH; Roop RM II
Microb Pathog; 1995 Nov; 19(5):227-84. PubMed ID: 8778563
[TBL] [Abstract][Full Text] [Related]
18. Deletion of purE attenuates Brucella melitensis 16M for growth in human monocyte-derived macrophages.
Drazek ES; Houng HS; Crawford RM; Hadfield TL; Hoover DL; Warren RL
Infect Immun; 1995 Sep; 63(9):3297-301. PubMed ID: 7642258
[TBL] [Abstract][Full Text] [Related]
19. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy.
Li ZQ; Shi JX; Fu WD; Zhang Y; Zhang J; Wang Z; Li TS; Chen CF; Guo F; Zhang H
Mol Immunol; 2015 Aug; 66(2):276-83. PubMed ID: 25899866
[TBL] [Abstract][Full Text] [Related]
20. Comparative proteome analysis of laboratory grown Brucella abortus 2308 and Brucella melitensis 16M.
Eschenbrenner M; Horn TA; Wagner MA; Mujer CV; Miller-Scandle TL; DelVecchio VG
J Proteome Res; 2006 Jul; 5(7):1731-40. PubMed ID: 16823981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
